Sino Biopharmaceutical LimitedHKEX: 1177

Next day disclosure return

Oct 13, 2026 at 4:55 AM EDT · Issued by Sino Biopharmaceutical Limited via HKEXnews

Filed with HKEX · Stock code 1177 · Oct 13, 2026 at 4:55 AM EDT · 6 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-831

Sino Biopharmaceutical Limited on 6ix

Earlier from Sino Biopharmaceutical

Voluntary announcement - completion of all subjects enrollment in the phase iii registrational clinical trial of TQC3721 inhalation suspension "PDE3/4 inhibitor"Oct 8
Monthly return of equity issuer on movements in securities for the month ended 30 September 2026Oct 1
Voluntary announcement - enter into strategic biosimilars partnership with stadaSep 28
Notification letter and request form for non-registered shareholdersSep 24
Notification letter and reply form for registered shareholdersSep 24

Later from Sino Biopharmaceutical

Voluntary announcement - latest research results on tq-A3334 "TLR7 agonist" and bepirovirsen "aso" to be presented at 2026 aasldOct 14

All Sino Biopharmaceutical news releases

Follow Sino Biopharmaceutical into a list and get an email when it puts out news.

Follow Sino Biopharmaceutical